Guidelines on laboratories' percutaneous transluminal coronary angioplasty (PTCA) volumes too low?
This article was originally published in Clinica
A new study confirms that cardiac catheterisation laboratories with higher volumes of percutaneous transluminal coronary angioplasty (PTCA) procedures have lower complication rates. However, Dr Stephen Kimmel and colleagues from University of Pennsylvania hospital report in JAMA (October 11th) that current guidelines of minimum volume to maintain competence may be too low. Data from 19,594 PTCA patients in 48 cardiac catheterisation centres in the US and Canada showed that increasing laboratory volume was associated with a significant reduction in mortality, emergency coronary artery bypass grafts and major complications.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.